While initially approved for Type 2 diabetes, its increasingly prescribed off-label for weight loss due to its strong results
On top of that, Superguts proprietary resistant starch blend supports blood sugar regulation, satiety, heart and metabolic health
One Years Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial
The findings were independent of overweight/obesity category at baseline, as seen in this subgroup analysis for the primary endpoint
If you have irregular cycles, severe dysmenorrhea, or hormonal imbalances, your provider should monitor GLP-1 tolerability more closely during your period
J Neurosci